Related references
Note: Only part of the references are listed.Pharmacogenetic studies of change in cortisol on ecstasy (MDMA) consumption
Kim Wolff et al.
JOURNAL OF PSYCHOPHARMACOLOGY (2012)
Ecstasy (MDMA)-induced hyponatraemia is associated with genetic variants in CYP2D6 and COMT
Katherine J. Aitchison et al.
JOURNAL OF PSYCHOPHARMACOLOGY (2012)
Sex Differences in 3,4-Methylenedioxymethamphetamine (MDMA; Ecstasy)-Induced Cytochrome P450 2D6 Inhibition in Humans
Samanta Yubero-Lahoz et al.
CLINICAL PHARMACOKINETICS (2011)
The Norepinephrine Transporter Inhibitor Reboxetine Reduces Stimulant Effects of MDMA (Ecstasy) in Humans
C. M. Hysek et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2011)
The Influence of Genetic and Environmental Factors among MDMA Users in Cognitive Performance
Elisabet Cuyas et al.
PLOS ONE (2011)
MDMA and methamphetamine: some paradoxical negative and positive mood changes in an acute dose laboratory study
Andrew C. Parrott et al.
PSYCHOPHARMACOLOGY (2011)
5-HTTLPR polymorphism, mood disorders and MDMA use in a 3-year follow-up study
Rocio Martin-Santos et al.
ADDICTION BIOLOGY (2010)
The influence of 5-HTT and COMT genotypes on verbal fluency in ecstasy users
Ana B. Fagundo et al.
JOURNAL OF PSYCHOPHARMACOLOGY (2010)
Overview of Amphetamine-Type Stimulant Mortality Data - UK, 1997-2007
Fabrizio Schifano et al.
NEUROPSYCHOBIOLOGY (2010)
Errors and reproducibility of DNA array-based detection of allelic variants in ADME genes: PHARMAchip™
Elisabet Cuyas et al.
PHARMACOGENOMICS (2010)
Neurotoxic Thioether Adducts of 3,4-Methylenedioxymethamphetamine Identified in Human Urine After Ecstasy Ingestion
Ximena Perfetti et al.
DRUG METABOLISM AND DISPOSITION (2009)
Sex Matters: Gonadal Steroids and the Brain
Elizabeth A. Young et al.
NEUROPSYCHOPHARMACOLOGY (2009)
Serotonergic Neurotoxic Thioether Metabolites of 3,4-Methylenedioxymethamphetamine (MDMA, Ecstasy): Synthesis, Isolation, and Characterization of Diastereoisomers
Nieves Pizarro et al.
CHEMICAL RESEARCH IN TOXICOLOGY (2008)
Sex differences in drug abuse
Jill B. Becker et al.
FRONTIERS IN NEUROENDOCRINOLOGY (2008)
The consequences of 3.4-methylenedioxymethamphetamine induced CYP2D6 inhibition in humans
Brian O'Mathuna et al.
JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY (2008)
Cognitive performance in recreational ecstasy polydrug users:: a two-year follow-up study
S. de Sola LLopis et al.
JOURNAL OF PSYCHOPHARMACOLOGY (2008)
Auditory event-related potentials (P3) and cognitive performance in recreational ecstasy polydrug users:: evidence from a 12-month longitudinal study
Susana de Sola et al.
PSYCHOPHARMACOLOGY (2008)
Plasma pharmacokinetics of 3.4-methylenedioxymethamphetamine after controlled oral administration to young adults
Erin A. Kolbrich et al.
THERAPEUTIC DRUG MONITORING (2008)
Catechol-O-Methyltransferase (COMT): A Gene Contributing to Sex Differences in Brain Function, and to Sexual Dimorphism in the Predisposition to Psychiatric Disorders
Paul J. Harrison et al.
NEUROPSYCHOPHARMACOLOGY (2008)
Pharmacological interaction between 3,4-methylenedioxymethamphetamine (Ecstasy) and paroxetine:: Pharmacological effects and pharmacokinetics
Magi Farre et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2007)
Evolving knowledge of sex differences in brain structure, function, and chemistry
Kelly P. Cosgrove et al.
BIOLOGICAL PSYCHIATRY (2007)
The role of estradiol and progesterone in modulating the subjective effects of stimulants in humans
Suzette M. Evans
EXPERIMENTAL AND CLINICAL PSYCHOPHARMACOLOGY (2007)
The current state of knowledge on age, sex, and their interactions on clinical pharmacology
J. B. Schwartz
CLINICAL PHARMACOLOGY & THERAPEUTICS (2007)
Are there sex differences associated with the effects of ecstasy/3,4-methylenedioxymethamphetamine (MDMA)?
Kelly Allott et al.
NEUROSCIENCE AND BIOBEHAVIORAL REVIEWS (2007)
High systolic blood pressure is associated with Val/Val genotype in the catechol-O-methyltransferase gene
Knut Hagen et al.
AMERICAN JOURNAL OF HYPERTENSION (2007)
Cortical trapping of α-[11C]methyl-L-tryptophan, an index of serotonin synthesis, is lower in females than males
Y. Sakai et al.
NEUROIMAGE (2006)
Implications of mechanism-based inhibition of CYP2D6 for the pharmacokinetics and toxicity of MDMA
Jiansong Yang et al.
JOURNAL OF PSYCHOPHARMACOLOGY (2006)
MDMA (ecstasy) pharmacokinetics in a CYP2D6 poor metaboliser and in nine CYP2D6 extensive metabolisers
R de la Torre et al.
EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY (2005)
Repeated doses administration of MDMA in humans:: pharmacological effects and pharmacokinetics
M Farré et al.
PSYCHOPHARMACOLOGY (2004)
Human pharmacology of MDMA -: Pharmacokinetics, metabolism, and disposition
R de la Torre et al.
THERAPEUTIC DRUG MONITORING (2004)
Diagnosing comorbid psychiatric disorders in substance abusers:: Validity of the Spanish versions of the psychiatric research interview for substance and mental disorders and the structured clinical interview for DSM-IV
M Torrens et al.
AMERICAN JOURNAL OF PSYCHIATRY (2004)
Drug addiction
J Camí et al.
NEW ENGLAND JOURNAL OF MEDICINE (2003)
Catechol O-methyltransferase val158-met genotype and individual variation in the brain response to amphetamine
VS Mattay et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2003)
Serotonin-related gene polymorphisms and central nervous system serotonin function
RB Williams et al.
NEUROPSYCHOPHARMACOLOGY (2003)
Unique CYP2D6 activity distribution and genotype-phenotype discordance in black Americans
A Gaedigk et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2002)
Determination of MDMA and its metabolites in blood and urine by gas chromatography-mass spectrometry and analysis of enantiomers by capillary electrophoresis
N Pizarro et al.
JOURNAL OF ANALYTICAL TOXICOLOGY (2002)
Which neuroreceptors mediate the subjective effects of MDMA in humans? A summary of mechanistic studies
ME Liechti et al.
HUMAN PSYCHOPHARMACOLOGY-CLINICAL AND EXPERIMENTAL (2001)
Gender differences in the subjective effects of MDMA
ME Liechti et al.
PSYCHOPHARMACOLOGY (2001)
Human pharmacology of 3,4-methylenedioxymethamphetamine (ecstasy):: Psychomotor performance and subjective effects
J Camí et al.
JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY (2000)
Non-linear pharmacokinetics of MDMA ('ecstasy') in humans
R de la Torre et al.
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY (2000)
Share Paper
